Fizyhealth
RxFul vs pass-through

How does RxFul pricing compare to pass-through alternatives?

RxFul charges published monthly SaaS tiers from $0 (GLP-only) through $1,997/mo (Gold) plus unpublished per-vial drug and 3PL fulfillment cost. Pass-through alternatives like Fizy Health show resolved 503A per-vial cost on each catalog and cart line before checkout, with a disclosed facilitation fee at payment and $0/mo plus pass-through pricing and 9% facilitation. RxFul optimizes white-label patient portal infrastructure; pass-through platforms optimize prescriber-side margin clarity and batch refill workflows.

This page compares total economics and workflow fit — not marketing slogans — so clinics can pick the layer that matches who places orders.

Compare Fizy Health vs RxFul

Proudly Partnered With

What is the economic difference between RxFul and pass-through ordering?

RxFul is a white-label patient portal and 3PL orchestration stack with published platform tiers and unpublished drug COGS. Pass-through ordering platforms surface 503A per-vial cost before checkout and charge platform economics as a disclosed facilitation fee — often with no monthly subscription on entry plans. The comparison is not which model is universally cheaper; it is which model matches your buyer (patient versus prescriber), your formulary gate (Bronze $997/mo versus free catalog browse), and whether you can model margin before onboarding completes.

Side-by-side comparison on the same SKUs

Run one month of real orders through both models on paper. RxFul column: monthly SaaS tier, per-vial drug quotes from onboarding, fulfillment per shipment at your volume, processing if separate. Pass-through column: per-vial 503A cost from catalog, facilitation fee at checkout, shipping on the order row. Include peptide and hormone SKUs if Bronze is required on RxFul — $997/mo must enter the RxFul column even at low volume.

High-volume patient-portal DTC brands may amortize RxFul SaaS to a small per-line cost while valuing white-label branding and API on Gold. Prescriber-led clinics batching 40 refills in one session may find pass-through batch cart economics dominate regardless of portal features.

Workflow fit matters as much as price

RxFul wins the evaluation when clinic-branded patient checkout is the product you are buying. Fizy Health wins when prescribers and staff place orders, need validation before payment, and route lines across multiple 503A partners in one cart. Different layers — some clinics eventually use both; many need only one.

Do not let either vendor own GLP-1 economics by default. Compare semaglutide and tirzepatide landed cost on the same strengths before you crown a winner. If pass-through pricing does not beat your all-in RxFul quote on the lines you ship most, keep your current stack.

Patient portal tiers — or prescriber pass-through checkout?

RxFul fits if

RxFul

You are buying white-label patient fulfillment infrastructure.

  • Patients checkout in your branded portal and SaaS tiers match your platform budget.
  • You will complete onboarding drug and fulfillment quotes and model TCO against pass-through options.
  • API, custom packaging, and priority allocation on Gold justify premium SaaS for your brand scale.
Consider Fizy Health if

Fizy Health

You are buying prescriber-side pass-through ordering with visible drug COGS.

  • Your team batches GLP-1, hormone, and peptide refills with per-vial cost before checkout.
  • You want to compare pass-through economics without $997/mo to unlock the catalog.
  • Cart validation and per-line HIPAA audit matter more than patient-portal white-label UX today.
If you choose Fizy Health

Pass-through outcomes RxFul tiers were not built to deliver.

Compare economics honestly — then pick the workflow your clinic actually runs.

See all features
Keep evaluating RxFul pricing

Related comparison pages.

See the full RxFul pricing guide
FAQ

RxFul versus pass-through pricing questions.

  • Economics

    Is pass-through pricing always cheaper than RxFul?

    No. Pass-through is more transparent on drug COGS, not automatically lower. Compare landed cost on your actual SKUs including RxFul SaaS amortization and fulfillment.

  • Catalog

    Does pass-through require a monthly tier for peptides?

    Fizy Health shows peptide and hormone pricing in catalog on the Free plan. RxFul requires Bronze ($997/mo) for peptides and full formulary beyond GLP-only.

  • Workflow

    Can I use RxFul and a pass-through platform together?

    They solve different layers. Some clinics use patient-portal vendors for DTC checkout and prescriber ordering separately. Evaluate whether you need both or one bottleneck dominates.

  • GLP-1

    Which model is better for high-volume GLP-1 clinics?

    If the bottleneck is prescriber batch refills and margin clarity, pass-through prescriber cart models fit. If the bottleneck is launching a patient-facing brand at scale, RxFul tiers may fit. Compare landed semaglutide and tirzepatide cost on both.

  • Evaluation

    What is the fastest honest comparison?

    Same five SKUs, same patient count, same month: total RxFul SaaS plus onboarding drug and fulfillment quotes versus Fizy Health per-vial cost plus facilitation and shipping from a test cart.

  • Switch

    When do clinics switch from RxFul to pass-through?

    Often when prescriber batch workflow outgrows patient-portal economics, or when $997/mo SaaS plus undisclosed drug COGS compresses margin below pass-through alternatives on their top SKUs.

Sources reviewed June 2026

  • RxFul public website and pricing page (rxful.com/pricing), reviewed June 2026.
  • Fizy Health platform capabilities reflect the live product.
Evaluate with real numbers

Run the comparison on your top five SKUs.

Pass-through per-vial pricing, one batch cart, and an honest landed-cost check against tiered SaaS. Free to start.

Start Ordering FreeFizy Health vs RxFul